Thursday, 29 March 2018

Pfizer's rare disease drug succeeds in late-stage study

(Reuters) - Pfizer Inc said on Thursday its drug for a rare and fatal disease associated with progressive heart failure met the main goal in a late-stage study.


from Reuters: Health News https://ift.tt/2GmZBBC

No comments:

Post a Comment